MedPath

KYOTO PREFECTURAL UNIVERSITY OF MEDICINE

KYOTO PREFECTURAL UNIVERSITY OF MEDICINE logo
πŸ‡―πŸ‡΅Japan
Ownership
Private
Established
1921-01-01
Employees
-
Market Cap
-
Website
http://www.f.kpu-m.ac.jp/j/english

Clinical Trials

253

Active:1
Completed:139

Trial Phases

5 Phases

Phase 1:16
Phase 2:12
Phase 3:4
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (252 trials with phase data)β€’ Click on a phase to view related trials

Not Applicable
216 (85.7%)
Phase 1
16 (6.3%)
Phase 2
12 (4.8%)
Phase 3
4 (1.6%)
Phase 4
4 (1.6%)

Efficacy of Denosumab on Normal BMD in Women Receiving Adjuvant Aromatase Inhibitors for Early Breast Cancer

Phase 3
Active, not recruiting
Conditions
Breast Cancer
Interventions
First Posted Date
2017-10-30
Last Posted Date
2023-10-06
Lead Sponsor
Kyoto Prefectural University of Medicine
Target Recruit Count
160
Registration Number
NCT03324932
Locations
πŸ‡―πŸ‡΅

Hisako Ono, Kyoto, Japan

Effects of Telmisartan on Ischemic Cardiovascular Events in High-risk Hypertensive Patients

Not Applicable
Terminated
Conditions
Acute Myocardial Infarction
Angina Pectoris
Acute Coronary Syndrome
Hypertension
Myocardial Ischemia
Interventions
Drug: Blopress (Candesartan)
First Posted Date
2009-03-18
Last Posted Date
2015-09-03
Lead Sponsor
Kyoto Prefectural University of Medicine
Target Recruit Count
1500
Registration Number
NCT00863980
Locations
πŸ‡―πŸ‡΅

Shakaihoken Kobe Central Hospital, Kobe, Japan

πŸ‡―πŸ‡΅

Akashi Municipal Hospital, Kobe, Japan

πŸ‡―πŸ‡΅

Kouseikai Takeda Hospital, Kyoto, Japan

and more 29 locations

Pitavastatin on Carotid Intima-media Thickness

Not Applicable
Conditions
Hyperlipidemia
Carotid Artery Diseases
Interventions
First Posted Date
2008-07-09
Last Posted Date
2009-09-10
Lead Sponsor
Kyoto Prefectural University of Medicine
Target Recruit Count
300
Registration Number
NCT00711919
Locations
πŸ‡―πŸ‡΅

Ayabe City Hospital, Ayabe, Kyoto, Japan

πŸ‡―πŸ‡΅

Fukuchiyama City Hospital, Fukuchiyama, Kyoto, Japan

πŸ‡―πŸ‡΅

Tanabe Central Hospital, Kyotanabe, Kyoto, Japan

and more 15 locations

Anti-Restenosis After AMI by Erythropoietin

Phase 4
Conditions
Acute Myocardial Infarction
First Posted Date
2007-01-17
Last Posted Date
2007-01-17
Lead Sponsor
Kyoto Prefectural University of Medicine
Target Recruit Count
72
Registration Number
NCT00423020
Locations
πŸ‡―πŸ‡΅

Kyoto Prefectural University of Medicine, Kyoto, Japan

Add-on Effects of Valsartan on Morbi- Mortality (KYOTO HEART Study)

Phase 4
Completed
Conditions
Hypertension
Ischemic Heart Disease
Congestive Heart Failure
Stroke
Interventions
Drug: Non-ARB
First Posted Date
2005-09-08
Last Posted Date
2012-12-12
Lead Sponsor
Kyoto Prefectural University of Medicine
Target Recruit Count
3031
Registration Number
NCT00149227
Locations
πŸ‡―πŸ‡΅

Kyoto Prefectural University of Medicine, Kyoto, Japan

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.